Astrogliopathy as a loss of astroglial protective function against glycoxidative stress under hyperglycemia

Clinical Neurology

Volumn 52, Issue 1, 2012, Pages 41-51

  Takahashi, Shinichi ^a   Izawa, Yoshikane ^a   Suzuki, Norihiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Astrocyte; Diabetes mellitus; Endoplasmic reticulum stress; Keap1 Nrf2; Pentose phosphate pathway

Indexed keywords

GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEXOSAMINE; PENTOSE PHOSPHATE; PROTEIN KINASE; PROTEIN KINASE RNA LIKE ER KINASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ACUTE DISEASE; ASTROGLIOPATHY; BRAIN DISEASE; BRAIN FUNCTION; CELL FUNCTION; CHRONIC DISEASE; ENDOPLASMIC RETICULUM STRESS; ENZYME REGULATION; ENZYME SUBSTRATE; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; MACROGLIA; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; PROTEIN PHOSPHORYLATION; REST; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; ASTROCYTES; BRAIN; GLUCOSE; GLYCOLYSIS; HUMANS; HYPERGLYCEMIA; OXIDATIVE STRESS; PENTOSE PHOSPHATE PATHWAY;

EID: 84856402602     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.52.41     Document Type: Review

References (96)

1. Clarke DD, Sokoloff L. Circulation and energy metabolism of the brain. In: Siegel G, Agranoff B, Albers RW, et al, editors. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. 6th ed. Philadelphia, USA: Lippincott-Raven; 1999. p. 637-669.
2. Dienel GA. Energy metabolism in the brain. In: Byrne JH, Roberts JL, editors. From molecules to networks: an introduction to cellular and molecular neuroscience. 2nd ed. London, UK: Acadmic Press; 2009. p. 49-110.
3. Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 2007;292:R18-36. (Pubitemid 46091599)
4. Mehta SL, Manhas N, Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 2007;54:34-66. (Pubitemid 46498164)
5. Jomova K, Vondrakova D, Lawson M, et al. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 2010;345:91-104.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820. (Pubitemid 34000785)
7. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-1625. (Pubitemid 40770750)
8. Tomlinson DR, Gardiner NJ. Glucose neurotoxicity. Nat Rev Neurosci 2008;9:36-45. (Pubitemid 350295687)
9. Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64-74. (Pubitemid 41790697)
10. Xu WL, von Strauss E, Qiu CX, et al. Uncontrolled diabetes increases the risk of Alzheimer's disease : a population-based cohort study. Diabetologia 2009;52:1031-1039.
11. Schernhammer E, Hansen J, Rugbjerg K, et al. Diabetes and the Risk of Developing Parkinson's Disease in Denmark. Diabetes Care 2011;34:1102-1108.
12. Xu Q, Park Y, Huang X, et al. Diabetes and Risk of Parkinson's Disease. Diabetes Care 2011;34:910-915.
13. Cox DJ, Kovatchev BP, Gonder-Frederick LA, et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 2005;28:71-77. (Pubitemid 40095785)
14. McCall AL. Altered glycemia and brain-update and potential relevance to the aging brain. Neurobiol Aging 2005;26 Suppl 1:70-75.
15. Sommerfield AJ, Deary IJ, Frier BM. Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care 2004;27:2335-2340. (Pubitemid 39281382)
16. Manschot SM, Biessels GJ, Valk H, et al. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 2007;50:2388-2397. (Pubitemid 47512398)
17. Ryan CM. Diabetes and brain damage: more (or less) than meets the eye? Diabetologia 2006;49:2229-2233. (Pubitemid 44359082)
18. Sima AAF. Encephalopathies : the emerging diabetic complications. Acta Diabetologica 2010;47:279-293.
19. Abramov AY, Scorziello A, Duchen MR. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci 2007;27:1129-1138. (Pubitemid 46203321)
20. Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal 2005;7:1140-1149. (Pubitemid 41232509)
21. Leopold JA, Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol 2005;25:1332-1340.
22. Duckrow RB, Bryan RM Jr. Regional cerebral glucose utilization during hyperglycemia. J Neurochem 1987;48:989-993. (Pubitemid 17018738)
23. Orzi F, Lucignani G, Dow-Edwards D, et al. Local cerebral glucose utilization in controlled graded levels of hyperglycemia in the conscious rat. J Cereb Blood Flow Metab 1988;8:346-356.
24. Blomqvist G, Grill V, Ingvar M, et al. The effect of hyperglycaemia on regional cerebral glucose oxidation in humans studied with [1-11C]-D-glucose. Acta Physiol Scand 1998;163:403-415. (Pubitemid 28375773)
25. Abe T, Takahashi S, Suzuki N. Oxidative metabolism in cultured rat astroglia: effects of reducing the glucose concentration in the culture medium and of D-aspartate or potassium stimulation. J Cereb Blood Flow Metab 2006;26:153-160. (Pubitemid 43151572)
26. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426-2432. (Pubitemid 32954818)
27. Kruyt ND, Biessels GJ, Devries JH, et al. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol 2010;6:145-155.
28. Macdougall NJ, Muir KW. Hyperglycaemia and infarct size in animal models of middle cerebral artery occlusion: systematic review and meta-analysis. J Cereb Blood Flow Metab 2011;31:807-818.
29. Quinn TJ, Lees KR. Hyperglycaemia in acute stroke - to treat or not to treat. Cerebrovasc Dis 2009;27 Suppl 1:148-155.
30. McCormick M, Hadley D, McLean JR, et al. Randomized, controlled trial of insulin for acute poststroke hyperglycemia. Ann Neurol 2010;67:570-578.
31. Uyttenboogaart M, Koch MW, Stewart RE, et al. Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke. Brain 2007;130 (Pt 6):1626-1630. (Pubitemid 47355928)
32. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-1687.
33. Takahashi S, Izawa Y, Suzuki N. Effects of acutely-increasing glucose concentrations on rates of glucose oxidation and ROS production in cultured rat neurons and astroglia Abstract Society for Neuroscience Program 2008: #637.11. (abstr).
34. Takahashi S. Energy metabolism of neurons and astroglia. Cerebral Blood Flow and Metabolism 2010;21:18-27.
35. Takahashi S, Izawa Y, Suzuki N. Roles of the Keapl/Nrf2 system in the regulation of pentose-phosphate pathway activity in astroglia cultured in high-glucose environments. The XXVth International Symposium on Cerebral blood Flow, Metabolism and Function & Xth International Conference on Qantification of Brain Function with PET 2011 (abstr).
36. Prichard J, Rothman D, Novotny E, et al. Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. Proc Natl Acad Sci U S A 1991;88:5829-5831. (Pubitemid 21914839)
37. Madsen PL, Cruz NF, Sokoloff L, et al. Cerebral oxygen/glucose ratio is low during sensory stimulation and rises above normal during recovery: excess glucose consumption during stimulation is not accounted for by lactate efflux from or accumulation in brain tissue. J Cereb Blood Flow Metab 1999;19:393-400. (Pubitemid 30161227)
38. Fox PT, Raichle ME. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci U S A 1986;83:1140-1144. (Pubitemid 16086428)
39. Fox PT, Raichle ME, Mintun MA, et al. Nonoxidative glucose consumption during focal physiologic neural activity. Science 1988;241:462-464.
40. Raichle ME, Mintun MA. Brain work and brain imaging. Annu Rev Neurosci 2006;29:449-476. (Pubitemid 44476853)
41. Vaishnavi SN, Vlassenko AG, Rundle MM, et al. Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci USA 2010;107:17757-17762.
42. Hilgetag CC, Barbas H. Are there ten times more glia than neurons in the brain? Brain Struct Funct 2009;213:365-366.
43. Dienel GA, Hertz L. Astrocytic contributions to bioenergetics of cerebral ischemia. Glia 2005;50:362-388. (Pubitemid 40780841)
44. Hyder F, Patel AB, Gjedde A, et al. Neuronal-glial glucose oxidation and glutamatergic-GABAergic function. Journal of Cerebral Blood Flow & Metabolism 2006;26:865-877. (Pubitemid 43980402)
45. Itoh Y, Abe T, Takaoka R, et al. Fluorometric determination of glucose utilization in neurons in vitro and in vivo. J Cereb Blood Flow Metab 2004;24:993-1003. (Pubitemid 39223623)
46. Nehlig A, Wittendorp-Rechenmann E, Lam CD. Selective uptake of [14C]2-deoxyglucose by neurons and astrocytes: high-resolution microautoradiographic imaging by cellular 14C-trajectography combined with immunohistochemistry. J Cereb Blood Flow Metab 2004;24:1004-1014. (Pubitemid 39223624)
47. Takahashi S, Driscoll BF, Law MJ, et al. Role of sodium and potassium ions in regulation of glucose metabolism in cultured astroglia Proc Natl Acad Sci U S A 1995;92:4616-4620.
48. Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 1994;91:10625-10629. (Pubitemid 24329051)
49. Magistretti PJ, Pellerin L, Rothman DL, et al. Energy on demand. Science 1999;283:496-497.
50. Pellerin L, Magistretti PJ. Food for thought: challenging the dogmas. J Cereb Blood Flow Metab 2003;23:1282-1286. (Pubitemid 37409790)
51. Pellerin L, Bouzier-Sore AK, Aubert A, et al. Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia 2007;55:1251-1262. (Pubitemid 47235366)
52. Jolivet R, Allaman I, Pellerin L, et al. Comment on recent modeling studies of astrocyte-neuron metabolic interactions. J Cereb Blood Flow Metab 2010;30:1982-1986.
53. Chih CP, Lipton P, Roberts EL Jr. Do active cerebral neurons really use lactate rather than glucose? Trends Neurosci 2001;24:573-578. (Pubitemid 32913386)
54. Chih CP, Roberts EL Jr. Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis. J Cereb Blood Flow Metab 2003;23:1263-1281.
55. Dienel GA, Cruz NF. Nutrition during brain activation: does cell-to-cell lactate shuttling contribute significantly to sweet and sour food for thought? Neurochem Int 2004;45:321-351. (Pubitemid 38625624)
56. Hertz L. The astrocyte-neuron lactate shuttle: a challenge of a challenge. J Cereb Blood Flow Metab 2004;24:1241-1248. (Pubitemid 39482486)
57. Hertz L, Dienel GA. Lactate transport and transporters: general principles and functional roles in brain cells. J Neurosci Res 2005;79:11-18. (Pubitemid 40116412)
58. Bak LK, Walls AB, Schousboe A, et al. Neuronal glucose but not lactate utilization is positively correlated with NMDA-induced neurotransmission and fluctuations in cytosolic Ca2 + levels. J Neurochem 2009;109 (Suppl 1):87-93.
59. DiNuzzo M, Mangia S, Maraviglia B, et al. Changes in glucose uptake rather than lactate shuttle take center stage in subserving neuroenergetics : evidence from mathematical modeling. Journal of Cerebral Blood Flow & Metabolism 2009;30:586-602.
60. Mangia S, Simpson IA, Vannucci SJ, et al. The in vivo neuron-to-astrocyte lactate shuttle in human brain: evidence from modeling of measured lactate levels during visual stimulation. Journal of neurochemistry 2009;109 Suppl 1:55-62.
61. Dienel GA, Cruz NF. Neighborly interactions of metabolically-activated astrocytes in vivo. Neurochem Int 2003;43:339-354. (Pubitemid 36561287)
62. Dienel GA, Cruz NF. Imaging brain activation: simple pictures of complex biology. Ann N Y Acad Sci 2008;1147:139-170.
63. Wamelink MM, Struys EA, Jakobs C. The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review. J Inherit Metab Dis 2008;31:703-717.
64. Surh YJ, Kundu JK, Na HK. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 2008;74:1526-1539.
65. Thimmulappa RK, Mai KH, Srisuma S, et al. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 2002;62:5196-5203. (Pubitemid 35033454)
66. Vargas MR, Johnson JA. The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev Mol Med 2009;11:e17.1-20.
67. Hothersall JS, Baquer N, Greenbaum AL, et al. Alternative pathways of glucose utilization in brain. Changes in the pattern of glucose utilization in brain during development and the effect of phenazine methosulfate on the integration of metabolic routes. Arch Biochem Biophys 1979;198:478-492. (Pubitemid 10141044)
68. Wilson JE. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. Journal of Experimental Biology 2003;206:2049-2057. (Pubitemid 36761808)
69. Alvarez E, Roncero I, Chowen JA, et al. Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain. J Neurochem 2002;80:45-53. (Pubitemid 34614576)
70. Roncero I, Alvarez E, Vazquez P, et al. Functional glucokinase isoforms are expressed in rat brain. J Neurochem 2000;74:1848-1857. (Pubitemid 30217639)
71. Roncero I, Alvarez E, Chowen JA, et al. Expression of glucose transporter isoform GLUT-2 and glucokinase genes in human brain. Journal of Neurochemistry 2004;88:1203-1210. (Pubitemid 38280688)
72. Dringen R, Pfeiffer B, Hamprecht B. Synthesis of the anti-oxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci 1999;19:562-569. (Pubitemid 29036007)
73. Lu SC. Regulation of glutathione synthesis. Mol Aspects Med 2009;30:42-59.
74. Izawa Y, Takahashi S, Suzuki N. Pioglitazone enhances pyruvate and lactate oxidation in cultured neurons but not in cultured astroglia. Brain Res 2009;1305:64-73.
75. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790. (Pubitemid 30212409)
76. Asanuma M, Miyazaki I, Diaz-Corrales FJ, et al. Neuro-protective effects of zonisamide target astrocyte. Ann Neurol 2010;67:239-249.
77. Saravia FE, Revsin Y, Gonzalez Deniselle MC, et al. Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res 2002;957:345-353. (Pubitemid 35356530)
78. Coleman E, Judd R, Hoe L, et al. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 2004;48:166-178. (Pubitemid 39545948)
79. Lebed YV, Orlovsky MA, Nikonenko AG, et al. Early reaction of astroglial cells in rat hippocampus to streptozotocin-induced diabetes. Neurosci Lett 2008;444:181-185.
80. Cheung KL, Kong AN. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. Aaps J 2010;12:87-97.
81. Guerrero-Beltrán CE, Calderón-Oliver M, Pedraza-Chaverri J, et al. Protective effect of sulforaphane against oxidative stress: Recent advances. Experimental and Pathology 2010 Dec 1. [Epub ahead of print];.
82. Danilov CA, Chandrasekaran K, Racz J, et al. Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation. Glia 2009;57:645-656.
83. Bloom DA. Phosphorylation of Nrf2 at Ser40 by Protein Kinase C in Response to Antioxidants Leads to the Release of Nrf2 from INrf2, but Is Not Required for Nrf2 Stabilization/Accumulation in the Nucleus and Transcriptional Activation of Antioxidant Response Element-mediated NAD (P) H: Quinone Oxidoreductase-1 Gene Expression. Journal of Biological Chemistry 2003;278:44675-44682. (Pubitemid 37377224)
84. Cullinan SB, Zhang D, Hannink M, et al. Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival. Molecular and Cellular Biology 2003;23:7198-7209. (Pubitemid 37211002)
85. Ozcan U. Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes. Science 2004;306:457-461. (Pubitemid 39372439)
86. Ito D, Tanaka K, Suzuki S, et al. Up-regulation of the Ire1-mediated signaling molecule, Bip, in ischemic rat brain. Neuroreport 2001;12:4023-4028. (Pubitemid 33152446)
87. Ito D, Suzuki N. Molecular pathogenesis of seipin/BSCL2-related motor neuron diseases. Ann Neurol 2007;61:237-250. (Pubitemid 46557348)
88. Sage AT, Walter LA, Shi Y, et al. Hexosamine biosynthesis pathway flux promotes endoplasmic reticulum stress, lipid accumulation, and inflammatory gene expression in hepatic cells. Am J Physiol Endocrinol Metab 2010;298:E499-511.
89. Matthews JA, Belof JL, Acevedo-Duncan M, et al. Glucosamine-induced increase in Akt phosphorylation corresponds to increased endoplasmic reticulum stress in astroglial cells. Mol Cell Biochem 2007;298:109-123. (Pubitemid 46605289)
90. Alvarez EO, Beauquis J, Revsin Y, et al. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behav Brain Res 2009;198:224-230.
91. Gandhi GK, Ball KK, Cruz NF, et al. Hyperglycaemia and diabetes impair gap junctional communication among astrocytes. ASN Neuro 2010;2:e00030 doi: 10.1042/AN20090048.
92. Ball KK, Harik L, Gandhi GK, et al. Reduced gap junctional communication among astrocytes in experimental diabetes: Contributions of altered connexin protein levels and oxidative-nitrosative modifications. J Neurosci Res 2011;doi:10.1002/jnr.22663.
93. Dhar A, Desai K, Kazachmov M, et al. Methylglyoxal production in vascular smooth muscle cells from different metabolic precursors. Metabolism 2008;57:1211-1220.
94. Chung SS, Ho EC, Lam KS, et al. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 2003;14 (Suppl 3):S233-236. (Pubitemid 36903931)
95. Sims-Robinson C, Kim B, Rosko A, et al. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol 2010;6:551-559.
96. Lo MC, Lu CI, Chen MH, et al. Glycoxidative stress-induced mitophagy modulates mitochondrial fates. Ann N Y Acad Sci 2010;1201:1-7.